United States · FDA National Drug Code directory
Cephalexin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 85766-191_4d82198d-9843-808b-e063-6394a90a5097
- Product NDC
- 85766-191
- Form
- CAPSULE
- Composition / generic term
- Cephalexin
- Labeler
- Sportpharm LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210329
- Source listing expiry
- 20271231
Source-listed ingredients
- CEPHALEXIN — 500 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 14 CAPSULE in 1 BOTTLE, PLASTIC (85766-191-14) · 85766-191-14
- 20 CAPSULE in 1 BOTTLE, PLASTIC (85766-191-20) · 85766-191-20
- 21 CAPSULE in 1 BOTTLE, PLASTIC (85766-191-21) · 85766-191-21
- 28 CAPSULE in 1 BOTTLE, PLASTIC (85766-191-28) · 85766-191-28
- 30 CAPSULE in 1 BOTTLE, PLASTIC (85766-191-30) · 85766-191-30
- 30 CAPSULE in 1 BLISTER PACK (85766-191-33) · 85766-191-33
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →